Drug recall · November 30, 2016
Ceftriaxone for Injection recall
Why: Labeling: Missing Label
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Ceftriaxone for Injection, USP, 1 gram, 10 Single use Vials, Rx only, For IM or I.V. Use, Manufactured by: Sandoz GMbH for Hospira Worldwide, Inc., Lake Forest, Il 60045, USA, Made in Austria, NDC 0409-7332-01
- Lots / codes
Sandoz - Lot GJ7151(Pfizer- Lot 670028M); Exp. 07/19
- Quantity
- 139,430 vials
- Company
- Sandoz Inc, Princeton, NJ
- Distribution
- WI
- Initiated
- October 19, 2016 · Voluntary: Firm initiated
- Classified
- November 19, 2016
- Reported
- November 30, 2016
- Ended
- July 27, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ceftriaxone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.